Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma

Onkologie

Volumn 29, Issue 11, 2006, Pages 531-533

  Schlaeppi, Marc Roger ^a   Korte, Wolfgang ^a   Von Moos, Roger ^a   Cerny, Thomas ^a   Gillessen, Silke ^a  

^a Kantonsspital ^*  (Switzerland)

Author keywords

DIC; Disseminated intravascular coagulation; Melanoma

Indexed keywords

CISPLATIN; DACARBAZINE; PROTEIN S 100; TUMOR MARKER; VINBLASTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISSEMINATED INTRAVASCULAR CLOTTING; HEMIHEPATECTOMY; HUMAN; LIVER DISEASE; MALE; MELANOMA; METASTASIS; PALLIATIVE THERAPY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DACARBAZINE; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; SKIN NEOPLASMS; TREATMENT OUTCOME; VINBLASTINE;

EID: 33750366012     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096148     Document Type: Article

References (12)

1. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
2. Susens GP, Hendrickson C, Barto DA, Sams BJ: Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: remission after treatment with 5-(3.3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Ann Intern Med 1976;84:175-6.
3. Barth A, Cerny T: Current aspects in the treatment of malignant melanoma. Schweiz Med Wochenschr 1994;124:1592-603.
4. Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G: Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost 2001;86:828-33.
5. Contrino J, Hair G, Kreutzer DL, Rickles FR: In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996;2:209-15.
6. Gambacorti Passerini C, Fossati G, Semeraro N, Donati MB, Gordon SG: Cancer procoagulant and haemostatic abnormalities in melanoma. Lancet 1986;1:920.
7. Bottasso B, Mari D, Coppola R, Santoro N, Vaglini M, Mannucci PM: Hypercoagulability and hyperfibrinolysis in patients with melanoma. Thromb Res 1996;81:345-52.
8. Ratnoff OD: Epsilon aminocaproic acid - a dangerous weapon. N Engl J Med 1969;280:1124-5.
9. Bhagwati N, Seno R, Dutcher JP, Oleksowicz L: Fulminant metastatic melanoma complicated by a microangiopathic hemolytic anemia. Hematopathol Mol Hematol 1998;11:101-8.
10. Huncharek M, Caubet JF, McGarry R: Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res 2001;11:75-81.
11. Eigentler TK, Caroli UM, Radny P, Garbe C: Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol 2003;4:748-59.
12. Ugurel S, Schadendorf D: Systemic treatment in advanced melanoma: innovative perspectives. Onkologie 2003;26:234-8.